Drugs of Abuse in Tel Aviv
Prof. Miguel Glatstein, Tel Aviv Sourasky Medical Center

Drug-facilitated sexual assault in Israel: A retrospective study from 2015 to 2022
Dr. Anat Shriki, Institute of Clinical Pharmacology and Toxicology
Sheba Medical Center

Severe outcomes following pediatric cannabis intoxication: A prospective cohort study of an international toxicology surveillance registry
Dr. Neta Cohen, Tel Aviv Sourasky Medical Center

Novel analytic methods for detection of substances in urine
Dr. Nitzan Tzanani, Israel Institute of Biological Research

Urinary drug screening of young children in the Pediatric Emergency Department
Dr. Renana Gelernter, Shamir Medical Center

Risk communication in non-conventional mass events
Dr. Moran Bodas, Tel Aviv Universuty

Treating high dose fentanyl intoxication
Dr. Shlomit Dachir, Israel Institute of Biological Research

“Catch-up therapy” based new countermeasure against percutaneous intoxication by low volatility organophosphorus- nerve agents
Dr. Eugenia Bloch-Shilderman, Israel Institute of Biological Research

Preparedness and response for toxicological mass casualty events
Dr. Ophir Lavon, Carmel Medical Center

Metamizole (Dipyrone) benefit risk profile
Roni Gat Wormser, Teva Pharmaceutical Industries

Transition to schizophrenia following emergency department visits due to substance use with and without psychosis
Prof. Yaron Finkelstein, The Hospital for Sick Children, Toronto, Canada

Clinical case discussion: an agitated patient presents to the ED
Experts panel

Amanita poisoning
Dr. Yael Lurie, Israel Poison Information Center